Cancer Care Program · highly regarded breast health teams in the region, featuring distinguished...

EINSTEIN.EDU 1.800.EINSTEIN

Cancer Care Program2018 Annual ReportWith Statistical Data From 2017

EINSTEIN.EDU 1-800-EINSTEIN

A Message from the Einstein Medical Center Montgomery Cancer Committee Chair

Community Outreach, Education and PreventionThe oncology program at Einstein Medical Center Montgomery participates in a variety of outreach, education and prevention programs for patients, families, caregivers and the general public.

William Biermann, MD, MBA

Cancer Committee Chairman Chief of MedicineEinstein Medical Center Montgomery

As chair of the Cancer Committee, I once again had the absolute privilege of working with the entire Committee membership this past year. I want to take this opportunity to thank the Committee, which represents a wide variety of clinical and ancillary services responsible for providing care for our patients, for another year of exceptional work and patient care.

Each member of the Committee is instrumental in our continual efforts to provide multidisciplinary patient-centered care at the highest level. The Committee meets bi-monthly and participates in a variety of activities, such as setting annual clinical and programmatic cancer goals, reviewing screening and educational outreach activities, and providing oversight of data managed by the oncology tumor registry team.

In 2018, the Cancer Committee at Einstein Medical Center Montgomery took on multiple quality studies and improvements, including utilizing depression screenings, piloting BioZorb technology in breast surgery, and setting two new goals, one clinical and one programmatic. On the clinical front, in order to improve the patient experience, an Inpatient Nurse Shadowing and Education Program was activated. This included the inpatient nurses at Einstein Medical Center shadowing their peers in the outpatient infusion suite as a way to improve their skills and knowledge of their patients with cancer.

Programmatically, our team established a cancer-related fatigue rehab program, in conjunction with MossRehab. The program provides physical therapy patient who suffer from cancer-related fatigue, and the results so far have been immediate and beneficial.

Outreach, education and prevention events

The cancer care program at Einstein Medical Center Montgomery also received national accreditation for another three-year period in 2018, in recognition of our adherence to rigorous standards of quality treatment by the Commission on Cancer, an affiliate of the American College of Surgeons.

The accreditation reflects our multidisciplinary approach to treating cancer, and is a testament to the time, effort and energy that the Committee has provided throughout this past year, as well as in years past. We continue to incorporate best practices into the treatment planning of our patients by utilizing national cancer care guidelines, and identifying available clinical trials that are the most beneficial for the patients seen at Einstein Medical Center Montgomery.

We are also very proud of the resources we provide to assist patients dealing with cancer. Our team of nurse navigators provides support and guidance to patients throughout the care continuum. Einstein Medical Center Montgomery’s partnerships with community organizations continues to flourish and provides additional resources to patients, as evidenced by collaborations with the American Cancer Society, Unite for Her and the Young Survival Coalition Program.

This is simply a brief highlight of some of the great work being accomplished to support our mission and help our patients, as we continue the fight against cancer. On behalf of the Cancer Committee and Oncology Program, I am proud to present the Einstein Medical Center Montgomery Cancer Care Program’s 2018 Annual Report.

PROGRAM & DESCRIPTION PARTICIPANTS

Breast Cancer ScreeningsProvided multiple mammography screening events to members of the Keystone Mercy Health Plan.

7

Breast Cancer Support GroupOpen-ended, mutual self-help/support group for all breast cancer survivors.

75

Korean Outreach Breast ScreeningPerformed mammography screenings specifically for the Korean community, using digital tomosynthesis (3D breast imaging).

300

General Cancer Support GroupOpen-ended mutual self-help/support group for patients and/or family members experiencing cancer.

99

HealthyWomen ProgramAs part of Pennsylvania Department of Health’s HealthyWoman Program, provided free breast and cervical cancer early detection screenings to underinsured women.

119

Lung Cancer ScreeningsScreenings for individuals meeting the high risk criteria - age 55-77, asymptomatic, 30-year pack history, and current or former smoker within 15 years - featuring a Low Dose CT scan.

223

Skin Cancer ScreeningOffered a free skin cancer/melanoma screening following the American Academy of Dermatology “Spotme” screening documentation.

21

Smoking Cessation ProgramSmoking cessation program sponsored by Einstein Medical Center Montgomery and following American Lung Association Program guidelines, the program features a step-by-step program for quitting smoking.

30

Unite For Her Wellness DayA day of complementary therapies for women undergoing breast cancer treatment to learn ways to manage side effects and symptoms, and become fully restored.

30

Montgomery County Wellness Expo Health ChecksConducted Health Checks at Montgomery County Community College, including a 26-panel blood screening and PSA test, as well as information and education on breast health, colon cancer, skin cancer and more.

200

2 3

OUTPATIENT MEDICAL ONCOLOGY AND HEMATOLOGY

The board-certified physicians, nurse practitioners and nurses that staff Outpatient Medical Oncology and Hematology provide services five days a week.

Through the accessibility of novel biological agents, we have expanded our armamentarium of treatments, which have improved response rates of chemotherapy without adding any additional toxicity or negatively impacting quality of life. The Outpatient Medical Oncology and Hematology service continues to provide state-of-the-art therapy in a friendly setting at Einstein Medical Center Montgomery.

INPATIENT MEDICAL ONCOLOGY – 3 WEST

3 West is a 24-bed unit specializing in the care of stable ventilator patients, as well as oncology, chemotherapy and hospice patients. One hundred percent of the RNs on 3 West have their Bachelor’s Degrees in Nursing.

Since opening in September 2012, the staff on 3 West has partnered with the Hospice and Palliative Care Team for in-depth training and daily rounding on shared patients. This enables the patients on 3 West to receive collaborative care that encompasses all aspects of their needs and enhances their experience.

Additionally, 3 West has partnered with our outpatient oncology group, as both a resource for education and a continuation of care for our patients who have been seen in the outpatient setting, but require hospitalization. The Oncology Nurse Navigators are available to both patients and staff, as they assist in bridging care from the outpatient to inpatient setting.

Through these multidisciplinary partnerships, 3 West is able to provide the best care possible for our patients throughout all phases of their illness.

RADIATION ONCOLOGY

Accredited by the American College of Radiology (ACR), the Radiation Oncology Department provides personalized services for the treatment

of cancer and benign diseases. Leading-edge technologies, such as 3D conformal external beam therapy; IMRT (Intensity Modulated Radiation Therapy) for areas such as prostate, head and neck cancers, and brain tumors; Stereotactic Radiosurgery (SRS) for brain tumors; and stereotactic body radiation therapy are utilized to deliver optimal patient care.

Our radiation oncologists use advanced radiation treatment planning techniques to tailor the radiation treatment program to the individual patient. These treatment and planning techniques are customized for each patient to maximize the chance for controlling the tumor while minimizing the risk of side effects. In addition, our radiation oncologists are actively involved in clinical trials that give patients access to the newest and most advanced breast cancer treatments available.

In preparation for these cancer treatments, the Radiation Oncology CT scanner with 4D capabilities is utilized to monitor respiratory motion and to minimize dose to normal surrounding tissue. Additional treatment options available through the Einstein Healthcare Network include: High Dose Rate (HDR) radiotherapy for gynecological malignancies.

BREAST HEALTH

The Breast Health Program at Einstein Medical Center Montgomery is home to one of the most highly regarded breast health teams in the region, featuring distinguished breast surgeons and radiologists. The program is recognized by the National Accreditation Program of Breast Centers (NAPBC) for delivering a high level of care and life-saving treatment options through individualized services and advanced technologies. It is the program’s emphasis on personal relationships and the latest techniques/technologies, including digital mammography and minimally invasive biopsies, which make EMCM’s Women’s Center a destination for breast health care.

BREAST IMAGING

Designated as a Breast Imaging Center of Excellence (BICOE) by the American College of Radiology (ACR) and accredited by the

ACR, according to the Mammography Quality Standards Act, Einstein Medical Center Montgomery offers advanced breast imaging technologies, including: digital mammography (digital breast tomosynthesis), ultrasound, magnetic resonance imaging (MRI) and all interventional breast procedures.

Digital breast tomosynthesis, the new 3D imaging technology, takes multiple low-dose images at different angles and displays them in thin multiple layers allowing our radiologists to look at smaller areas and see “through” breast tissue better than a 2D mammogram. Tomosynthesis reduces the number of false-positive results and the need to come back for further testing. The radiology breast team participates in research trials that are designed to enhance their diagnostic skills at finding and diagnosing breast abnormalities.

INTERVENTIONAL RADIOLOGY

Our Interventional Radiology team utilizes the most advanced technology available to perform image-guided procedures to treat a wide variety of diseases throughout the body, including cancer. Interventional Radiology treatments minimize risk, require little to no incisions, are generally performed with sedation rather than general anesthesia, and more importantly, have less pain and recovery time than conventional surgery.

HOSPICE

Einstein Medical Center Montgomery’s Hospice Program is a community-centered healthcare program for individuals who are in the last phases of terminal illness and who elect not to pursue curative treatments. The hospice staff provides outpatient service to patients in their home, assisted living facilities and nursing

homes. The focus of care is on pain and symptom management, psychosocial support for the patient and family, counseling for caregivers and spiritual support.

Under the direction of the patient’s physician, and in conjunction with our hospice medical directors, our hospice team – which consists of the medical director, hospice manager, hospice RNs, home health aides, social workers, chaplain and volunteers – works together to follow a personalized plan of physical, emotional and spiritual care, designed to meet the changing needs of both the patient and their family.

For patients whose pain or symptoms are unable to be controlled in the home setting, short-term inpatient hospice may be an option. Our inpatient hospice service is designed to meet the needs of the terminally ill patient and their family. Hospice care is not limited to oncology, but approximately 30% of hospice patients are cancer patients.

PALLIATIVE CARE

Our Palliative Care program is designed to meet the needs of patients who have complex pain or symptoms, but are not on hospice care. A team of professionals consult on medically complex patients to achieve symptom management, discuss advance directives and provide a holistic approach to the patient experience.

Einstein Medical Center Montgomery’s Home Health, Hospice and Palliative Care Program is recognized for having a Medical Director nationally certified in hospice and palliative medicine. This high level of expertise contributes to the overall exceptional patient satisfaction ratings for the program.

Cancer Committee: A Multidisciplinary Team

Einstein Medical Center Montgomery’s Cancer Committee is comprised of a wide variety of clinical and ancillary services responsible for providing care for our patients, including:

Digital breast tomosynthesis, the new 3D imaging technology, takes multiple low-dose images at different angles allowing radiologists to look at smaller areas and see “through” breast tissue better than a 2D mammogram.

4 5

The cancer registrar collects and documents demographic information, pathological and diagnostic testing results, treatment information and follow-up data. This is done in accordance with the requirements of the following regulatory agencies: The Department of Public Health, Pennsylvania Cancer Registry, The SEER Program of the National Cancer Institute (NCI), and the Commission on Cancer (CoC) of the American College of Surgeons (ACoS). The reference date for the Einstein Montgomery Medical Center cancer data base is January 1, 2003.

» A total of 654 cases were entered into the data base in 2017. 612 of these cases were analytic and 42 were non-analytic cases. There have been 8,630 cases accessioned in the registry since the reference date in 2003. Active follow-up is maintained on approximately 3,526 patients with a target follow-up rate of 80%. Each case is followed annually to monitor diagnostic and treatment outcomes and to provide accurate data to calculate survival rates.

» The cancer registry data are reviewed for accuracy, timeliness and quality by a physician member of the Cancer Committee. Availability of the cancer data to the Cancer Committee, Hospital Administration and physicians facilitates evaluation of outcomes of treatment and assists in the assessment of the needs of the community. Additionally, physician review of Treatment Planning, Collaborative staging, American Joint Committee on Cancer (AJCC) TNM staging, College of American Pathologists (CAP) Protocols for pathology report and National Comprehensive Cancer Network (NCCN) guidelines is completed quarterly.

» The cancer registrars participated in state and nationwide cancer registry educational activities throughout 2017.

» As required, the Einstein Medical Center Montgomery cancer registry submits data to the Pennsylvania State Cancer Registry. The state registry is a population-based registry and is a member of the Surveillance, Epidemiology and End Results Program of the National Cancer Institute.

» The CoC recognizes Einstein Medical Center Montgomery as an approved Community Hospital Cancer Program. National Cancer Data Base’s (NCDB) Annual Call for Data was submitted this year, error free.

» The American Society for Clinical Oncology (ASCO) and NCCN Quality Measures & Guidelines continue to be reviewed for Breast and Colorectal Cancers, which allows opportunity for practice improvements. Participation in NCDB Rapid Quality Reporting System (RQRS) provides information on compliance with NCCN guidelines for Breast and Colon cases, and enables registrars to add new treatment information.

» The registry utilizes METRIQ, the cancer data software contracted through Elekta. The METRIQ cancer registry system meets regulatory reporting requirements and provides ready access to the data required to effectively review, analyze and ultimately improve clinical outcomes.

2017 Top-Five Sites For Cancer

654

Cancer registry is an integral part of the Einstein Medical Center Montgomery Cancer Care Program. The registry is an information system that monitors each type of cancer diagnosed and/or treated at our facility. The primary function is to provide continuum data management services under the support and leadership of the Cancer Committee.

Cases were entered into the data

A Total of

Cancer Registry Summary

TOP Sites for Einstein Medical Center Montgomery 2017 Analytical and Non-Analytical

6%

COLORECTAL

LUNG

BREAST

KIDNEY

PROSTATE

ALL OTHER

6 7

45%

20%

13%10%

6%

2017 Top-Five Sites with Stage at Diagnosis

2017 Analytical Breast Cases

STAGE 0 14

STAGE 1 52

STAGE 2 27

STAGE 3 7

STAGE IV 5

UNK 3

0

10

20

30

40

50

60

70

STAGE 0 STAGE 1 STAGE 2 STAGE 3 STAGE IV UNK

357

27

52

14

!1

2017 Analytical Lung Cases

2017 Analytical Colorectal Cases

2017 Analytical Colorectal Cases

STAGE 0 0

STAGE 1 8

STAGE 2 9

STAGE 3 20

STAGE IV 34

UNK 2

0

5

10

15

20

25

30

35


2

34

20

98

0

!1

STAGE 0 0

STAGE 1 4

STAGE 2 11

STAGE 3 6

STAGE IV 8

UNK 3

0

4

8

12


3

8

6

11

4

0

!1

STAGE 0 0

STAGE 1 5

STAGE 2 28

STAGE 3 7

STAGE IV 5

UNK 1

0

8

15

23

30


157

28

50

!1

STAGE 0 1

STAGE 1 21

STAGE 2 2

STAGE 3 5

STAGE IV 3

UNK 2

0

5

10

15

20


23

52

21

1

!1

2017 Analytical Prostate Cases

2017 Analytical Kidney Cases

8 9

Comparison of Units Sold by Year

DESCRIPTION BCSRT HT NBX MAC BCS

EMCM 82 94 82 100 82

PA 88 94 88 94 72

ALL COC PROGRAMS

90 92 90 93 67

nBx

ALL COC PROGRAMS89.6%

PA87.9%EMCM

82.2%

EMCM PA ALL COC PROGRAMS

!4



EMCM 94 94 82 100 82

PA 94 94 88 94 72

ALL COC PROGRAMS

92 92 90 93 67

HT


PA94.1%

EMCM93.8%


!4



EMCM 93 94 82 100 82

PA 94 94 88 94 72

ALL COC PROGRAMS

91 92 90 93 67

BCSRT


PA94.3%

EMCM93.1%


!4



EMCM 82 94 82 100 82

PA 72 94 88 94 72

ALL COC PROGRAMS

67 92 90 93 67

BCS


PA71.6%

EMCM82.0%


!4



EMCM 100 94 82 100 82

PA 94 94 88 94 72

ALL COC PROGRAMS

93 92 90 93 67

MAC


PA93.5%

EMCM100.0%


!4

Einstein Cancer Care Reports Five Quality Indicators

HOW WE COMPARE TO THE NATIONAL CANCER DATABASE

In 1998, a Presidential Commission recommended the creation of a national forum in which healthcare’s many stakeholders could, together, find ways to improve the quality and safety of America’s healthcare.This recommendation led to the creation of NQF, a private, not-for-profit, public benefit corporation established in 1999 to standardize healthcare quality measurement and reporting.

Established as a public-private partnership, the NQF has broad participation from all parts of the healthcare system, including national, state, regional and local groups representing consumers, public and private purchasers, employers, healthcare professionals, provider organizations, health plans, and others involved in healthcare research or quality improvement. Together, the organizational members of the NQF work to promote a common approachto measuring healthcare quality and fostering system-wide capacity for quality improvement.

The Commission on Cancer (CoC), through the Cancer Program Practice Reports (CP3R), promotes five quality indicators utilizing the data submitted to the National Cancer Database. The data are from 2014.

Einstein Medical Center Montgomery’s CP3R Performance



EMCM 93 94 82 100 82

PA 94 94 88 94 72

ALL COC PROGRAMS

91 92 90 93 67

0%

25%

50%

75%

100%

BCSRT HT nBx MAC BCS

67.1%

92.6%89.6%91.5%90.9%

71.6%

93.5%87.9%

94.1%94.3%

82.0%

100.0%

82.2%

93.8%93.1%


!4



EMCM 93 94 82 100 82

PA 94 94 88 94 72

ALL COC PROGRAMS

91 92 90 93 67

0%

25%

50%

75%

100%


67.1%

92.6%89.6%91.5%90.9%

71.6%

93.5%87.9%

94.1%94.3%

82.0%

100.0%

82.2%

93.8%93.1%


!4



EMCM 93 94 82 100 82

PA 94 94 88 94 72

ALL COC PROGRAMS

91 92 90 93 67

0%

25%

50%

75%

100%


67.1%

92.6%89.6%91.5%90.9%

71.6%

93.5%87.9%

94.1%94.3%

82.0%

100.0%

82.2%

93.8%93.1%


!4

10 11

Fundraiser Results by Salesperson

PARTICIPANT UNITS SOLD

EMCM 82

PA 72

ALL COC 67

60%

73%

87%

100%

EMCM PA ALL COC

67.1%71.6%

82.0%

Column and bar charts compare values in a single category. For example, you can compare the number of products sold by each salesperson.

!1



EMCM 82.2

PA 88

ALL COC 90

75%

83%

92%

100%

EMCM PA ALL COC

89.6%87.9%

82.2%


!1

Needle Biopsy (nBx)

Image or palpation-guided needle biopsy to the primary site is performed to establish diagnosis of breast cancer. While Einstein Medical Center Montgomery’s compliance with this measure, at 82.2%, is below the average of all CoC approved programs’ norms of 89.6%, it exceeds the standard requirement of 80%.



EMCM 100

PA 94

ALL COC 93

75%

83%

92%

100%

EMCM PA ALL COC

92.6%93.5%

100.0%


!1

Mastectomy/Radiation Therapy for Women with Four or More Positive Lymph Nodes (MAC)

Radiation therapy is recommended or administered following any mastectomy within 1 year (365 days) of diagnosis of breast cancer for women with ≥ 4 positive regional lymph nodes. Einstein Medical Center Montgomery’s compliance with this measure is very favorable at 100%, compared to all CoC approved programs’ norm of 92.6%.



EMCM 93.8

PA 94

ALL COC 92

86%89%92%95%98%

EMCM PA ALL COC

91.5%

94.1%93.8%


!1

Tamoxifen or Third Generation Aromatase Inhibitor in Hormone Receptor Positive Breast Cancer Patients (HT)

(NQF #0220) Tamoxifen or third generation aromatase inhibitor is recommended or administered within 1 year (365 days) of diagnosis for women with AJCC T1cN0M0 or Stage IB - III hormone receptor positive breast cancer. While Einstein Medical Center Montgomery’s compliance with this measure, at 93.8%, is below the average of all Pennsylvania CoC approved programs’ norms of 94.1%, it exceeds the national average of 91.5%.

CP3R and EMCM’s Performance for Breast Cancer



EMCM 93.1

PA 94

ALL COC 91

88%91%93%96%98%

EMCM PA ALL COC

90.9%

94.3%93.1%


!1

Breast Conserving Surgery and Radiation Therapy (BCSRT)(NQF #219) Radiation therapy is administered within 1 year (365 days) of diagnosis for women under age 70 receiving breast conserving surgery for breast cancer. While Einstein Medical Center Montgomery’s compliance with this measure, at 93.1%, is below the average of all Pennsylvania CoC approved programs’ norms of 94.3%, it exceeds the national average of 90.9%.

1312

Breast Conservation Surgery (BCS)

Breast conservation surgery rate for women with AJCC clinical stage 0, I, or II breast cancer. Einstein Medical Center Montgomery’s compliance with this measure is very favorable at 82%, compared to all CoC approved programs’ norm of 67.1%.

PRIMARY SITE TOTAL (%) ANALYTIC NON-ANALYTIC

ORAL CAVITY & PHARYNX 7 (1.1%) 6 1

Tongue 3 (0.5%) 3 0

Gum & Other Mouth 1 (0.2%) 1 0

Tonsil 3 (0.5%) 2 1

DIGESTIVE SYSTEM 116 (17.7%) 106 10

Esophagus 9 (1.4%) 9 0

Stomach 14 (2.1%) 12 2

Small Intestine 3 (0.5%) 3 0

Colon Excluding Rectum 32 (4.9%) 30 2

Cecum 5 5 0

Appendix 1 1 0

Ascending Colon 11 10 1

Hepatic Flexure 1 1 0

Transverse Colon 1 1 0

Descending Colon 1 1 0

Sigmoid Colon 7 6 1

Large Intestine, NOS 5 5 0

Rectum & Rectosigmoid 19 (2.9%) 18 1

Rectosigmoid Junction 5 5 0

Rectum 14 13 1

Anus, Anal Canal & Anorectum 1 (0.2%) 1 0

Liver & Intrahepatic Bile Duct 22 (3.4%) 19 3

Liver 15 13 2

Intrahepatic Bile Duct 7 6 1

Gallbladder 2 (0.3%) 1 1

Other Biliary 3 (0.5%) 3 0

Pancreas 10 (1.5%) 9 1

Peritoneum, Omentum & Mesenter 1 (0.2%) 1 0

RESPIRATORY SYSTEM 101 (15.4%) 95 6

Nose, Nasal Cavity & Middle Ear 1 (0.2%) 1 0

Larynx 3 (0.5%) 3 0

Lung & Bronchus 96 (14.7%) 90 6

Trachea, Mediastinum & Other Res 1 (0.2%) 1 0

SKIN EXCLUDING BASAL & SQU 19 (2.9%) 18 1

Melanoma – Skin 17 (2.6%) 16 1

Other Non-Epithelial Skin 2 (0.3%) 2 0

BASAL & SQUAMOUS SKIN 1 (0.2%) 0 1

Basal/Squamous cell carcinomas o 1 (0.2%) 0 1

BREAST 134 (20.5%) 133 1

2017 Primary Site Table 2017 Primary Site TableFEMALE GENITAL SYSTEM 38 (5.8%) 34 4

Cervix Uteri 3 (0.5%) 3 0

Corpus & Uterus, NOS 25 (3.8%) 23 2

Corpus Uteri 22 20 2

Uterus, NOS 3 3 0

Ovary 3 (0.5%) 3 0

Vagina 1 (0.2%) 1 0

Vulva 2 (0.3%) 1 1

Other Female Genital Organs 4 (0.6%) 3 1

MALE GENITAL SYSTEM 57 (8.7%) 49 8

Prostate 56 (8.6%) 48 8

Testis 1 (0.2%) 1 0

URINARY SYSTEM 73 (11.2%) 70 3

Urinary Bladder 27 (4.1%) 26 1

Kidney & Renal Pelvis 40 (6.1%) 38 2

Ureter 5 (0.8%) 5 0

Other Urinary Organs 1 (0.2%) 1 0

BRAIN & OTHER NERVOUS SYS 18 (2.8%) 18 0

Brain 5 (0.8%) 5 0

Cranial Nerves Other Nervous Syst 13 (2.0%) 13 0

ENDOCRINE SYSTEM 25 (3.8%) 24 1

Thyroid 21 (3.2%) 20 1

Other Endocrine including Thymus 4 (0.6%) 4 0

LYMPHOMA 27 (4.1%) 24 3

Hodgkin Lymphoma 6 (0.9%) 6 0

Non-Hodgkin Lymphoma 21 (3.2%) 18 3

NHL - Nodal 13 10 3

NHL - Extranodal 8 8 0

MYELOMA 4 (0.6%) 3 1

LEUKEMIA 14 (2.1%) 13 1

Lymphocytic Leukemia 7 (1.1%) 7 0

Chronic Lymphocytic Leukemia 6 6 0

Other Lymphocytic Leukemia 1 1 0

Myeloid & Monocytic Leukemia 7 (1.1%) 6 1

Acute Myeloid Leukemia 5 4 1

Chronic Myeloid Leukemia 2 2 0

MESOTHELIOMA 4 (0.6%) 3 1

KAPOSI SARCOMA 1 (0.2%) 1 0

MISCELLANEOUS 15 (2.3%) 15 0

TOTAL 654 612 42

14 15

2018 Cancer Committee Membership William Biermann, MD, MBA, FACP Medical Director, Medical Oncology Cancer Committee Chairman

Jane Blanas Representative, American Cancer Society

Shavon Boxman, MA, CCC-SLP Speech Pathologist, Rehabilitation

Jenna Caffrey, RD, LDN Clinical Dietitian, Nutrition Services

Carol Casatelli Physician Liaison

Linda Case, RHIT, CTR Certified Tumor RegistrarCancer Registry Quality Coordinator

Brandi Chawaga Director, Community Wellness

Joanne Cipollini, MSN, RN Oncology Nurse Navigator Community Outreach Coordinator

Mary Galetti, BS, RN, OCN Clinical Trials Supervisor Clinical Research Coordinator

Julie Gubernick, MD, FACR Chief, Radiology

Barb Heinzmann, RN, CBCN, BSN Nurse Navigator, Breast Health Program

Ahashta Johnson, MD Palliative Care Physician, Home Health, Hospice and Palliative Care

Jaclyn Ladden, PT, DPT, CLT-LANA Physical Therapist, Rehabilitation

Sara Ludwig-Nagy, RN Nurse Educator, 4 West

Pat Modafferi, MHA Vice President, Health Care Services Cancer Conference Coordinator

Mark Morginstin, DO Medical Oncologist/Hematologist

Jermine Mousa, PharmD Manager, Pharmacy

Monica Nash, RN, BSN Nurse Director, 3 West

Patricia Perosio, MD, FASCP, FCAP Pathologist, Department of Pathology

Cheryl Quintanilla, MBA, CTR Certified Tumor Registrar Oncology Data Analyst

Elton Richardson, LSW Social Worker, Care Management Psychosocial Services Coordinator

Marc Schaller, DPT, MBA Cancer Service Line Administrator - EMCM Cancer Program Administrator

Robert Schiowitz, MD, FACS General Surgeon, Surgery

Leah Sheppard, MS Associate Vice President Corporate Marketing and Communications

Jennifer Simmons, MD, FACS Director, Breast Surgery Director, Breast Health Program

Lawrence Solin, MD, FACR, FASTRO Chair, Radiation Oncology

Kim Tissue, RN, MHA Quality Coordinator Quality Management

Chase Wexler Senior Marketing Manager Corporate Marketing and Communications

EINSTEIN.EDU 1-800-EINSTEIN

Cancer Care Program · highly regarded breast health teams in the region, featuring distinguished...

Documents

Transcript of Cancer Care Program · highly regarded breast health teams in the region, featuring distinguished...